Dosidal · Switzerland
Gliclazid-Mepha 60 retard, Depotabs
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:65571 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 65571 atc: A10BB09 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2015-02-26 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: A10BB09 authorisation_number: 65571 form: RETT holder: Mepha Pharma AG holder_partner_nr: 1006155 it_number: 07.06.2. name: Gliclazid-Mepha 60 retard, Depotabs state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53VZYE5qHVGrkW_IlmBeSUBZ2QiwpoqsIKB33F90gBSJzGu6mepIug3HWDw-_dD5_53XEpRh7SILRHpMz0gIMVQAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65571 · Related records in other markets · Dosidal